SPCC (Sharing Progress in Cancer Care) posted the following on LinkedIn:
“Is it safe to pause treatment – or even stop it altogether in cases of minimal residual disease? Can strategies for treatment-free remission with monitoring that are becoming standard in chronic myeloid leukaemia be translated to solid tumours?
Janet Fricker explores some of the challenges and potential solutions.”